N6,5′-disubstituted adenosine derivatives as partial agonists for the human adenosine A3 receptor

被引:42
作者
van Tilburg, EW
Künzel, JVD
de Groote, M
Vollinga, RC
Lorenzen, A
IJzerman, AP
机构
[1] Leiden Amsterdam Ctr Drug Res, Div Med Chem, NL-2300 RA Leiden, Netherlands
[2] Univ Heidelberg, Inst Pharmacol, D-6900 Heidelberg, Germany
关键词
D O I
10.1021/jm981090+
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
5'-(Alkylthio)-substituted analogues of N-6-benzyl- and N-6-(3-iodobenzyl)adenosine were synthesized in 37-61% overall yields. The affinities of these compounds for the adenosine A(1), A(2A), and A(3) receptors were determined using rat brain cortex, rat brain striata, and stably transfected human A(3) receptors in HEK 293 cells, respectively. The compounds proved to be selective for the adenosine A(3) receptor and displayed affinities in the nanomolar range. Compounds 8, 10, and 11 had the highest affinities for the A(3) receptor with K-i values ranging from 8.8 to 27.7 nM. In the N-6-benzyl series, compound 4 (LUF 5403), with a 5'-methylthio group, maintained a reasonable affinity and had the highest selectivity for the A(3) receptor. Compound 12 (LUF 5411), with an N-6-(3-iodobenzyl) group and a 5'-(n-propylthio) substituent, had the highest A(3) selectivity of all of the compounds and also displayed high affinity for this receptor (K-i = 44.3 nM). The compounds were also evaluated for their ability to stimulate [S-35]GTP gamma[S] binding in cell membranes expressing the human adenosine A(3) receptor. It appeared that the N-6,5'-disubstituted adenosine derivatives behaved as partial agonists. Compounds 2, 4, 8, and 10 had the highest intrinsic activities. Additionally, when tested in a cAMP assay, these compounds also behaved as partial agonists.
引用
收藏
页码:1393 / 1400
页数:8
相关论文
共 37 条
[1]   Synthesis and biological activity of a new series of N6-arylcarbamoyl, 2-(Ar)alkynyl-N6-arylcarbamoyl, and N6-carboxamido derivatives of adenosine-5′-N-ethyluronamide as A1 and A3 adenosine receptor agonists [J].
Baraldi, PG ;
Cacciari, B ;
de Las Infantas, MJP ;
Romagnoli, R ;
Spalluto, G ;
Volpini, R ;
Costanzi, S ;
Vittori, S ;
Cristalli, G ;
Melman, N ;
Park, KS ;
Ji, XD ;
Jacobson, KA .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (17) :3174-3185
[2]   Novel N-6-(substituted-phenylcarbamoyl)adenosine-5'-uronamides as potent agonists for A(3) adenosine receptors [J].
Baraldi, PG ;
Cacciari, B ;
Spalluto, G ;
Ji, XD ;
Olah, ME ;
Stiles, G ;
Dionisotti, S ;
Zocchi, C ;
Ongini, E ;
Jacobson, KA .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (03) :802-806
[3]   CONVENIENT PREPARATION OF S-ADENOSYLHOMOCYSTEINE AND RELATED COMPOUNDS [J].
BORCHARDT, RT ;
HUBER, JA ;
WU, YS .
JOURNAL OF ORGANIC CHEMISTRY, 1976, 41 (03) :565-567
[4]   NUCLEOTIDES .40. O-2-5'-CYCLOURIDINE AND A SYNTHESIS OF ISOCYTIDINE [J].
BROWN, DM ;
TODD, AR ;
VARADARAJAN, S .
JOURNAL OF THE CHEMICAL SOCIETY, 1957, (FEB) :868-872
[5]   NUCLEOTIDES .39. 5'-DEOXY-5'-IODO-O-2-2'-CYCLOURIDINE - AN X-RAY CRYSTALLOGRAPHIC STUDY [J].
BROWN, DM ;
COCHRAN, W ;
MEDLIN, EH ;
VARADARAJAN, S .
JOURNAL OF THE CHEMICAL SOCIETY, 1956, (DEC) :4873-4876
[6]  
BRUNS RF, 1980, CAN J PHYSIOL PHARM, V58, P673, DOI 10.1139/y80-110
[7]  
BRUNS RF, 1986, MOL PHARMACOL, V29, P331
[8]   AGONIST ACTIVITY OF 2-SUBSTITUTED AND 5'-SUBSTITUTED ADENOSINE-ANALOGS AND THEIR N6-CYCLOALKYL DERIVATIVES AT ADENOSINE-A1 AND ADENOSINE-A2 RECEPTORS COUPLED TO ADENYLATE-CYCLASE [J].
DALY, JW ;
PADGETT, WL .
BIOCHEMICAL PHARMACOLOGY, 1992, 43 (05) :1089-1093
[9]  
DODS RF, 1969, TETRAHEDRON LETT, P165
[10]   SYNTHESIS AND BIOLOGICAL-ACTIVITIES OF SOME N6-(NITROBENZYL)ADENOSINES AND N6-(AMINOBENZYL)ADENOSINES [J].
DUTTA, SP ;
TRITSCH, GL ;
COX, C ;
CHHEDA, GB .
JOURNAL OF MEDICINAL CHEMISTRY, 1975, 18 (08) :780-783